Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 8 | 2025 | 393 | 1.150 |
Why?
|
| Encephalitis | 3 | 2024 | 123 | 0.840 |
Why?
|
| Immunologic Factors | 4 | 2025 | 190 | 0.650 |
Why?
|
| Status Epilepticus | 2 | 2024 | 159 | 0.630 |
Why?
|
| Hashimoto Disease | 2 | 2024 | 31 | 0.560 |
Why?
|
| Brain Diseases | 2 | 2023 | 298 | 0.440 |
Why?
|
| Neuromyelitis Optica | 2 | 2023 | 34 | 0.370 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2021 | 11 | 0.340 |
Why?
|
| Central Nervous System Diseases | 1 | 2021 | 98 | 0.320 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 279 | 0.270 |
Why?
|
| Fingolimod Hydrochloride | 2 | 2024 | 34 | 0.250 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2025 | 148 | 0.250 |
Why?
|
| Opsoclonus-Myoclonus Syndrome | 1 | 2026 | 4 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2026 | 3751 | 0.230 |
Why?
|
| Interferon beta-1a | 1 | 2025 | 23 | 0.230 |
Why?
|
| Interferon-beta | 1 | 2025 | 56 | 0.230 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2026 | 50 | 0.220 |
Why?
|
| Immunosuppressive Agents | 3 | 2024 | 653 | 0.220 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 508 | 0.210 |
Why?
|
| Autoantibodies | 5 | 2026 | 436 | 0.210 |
Why?
|
| Epilepsy | 1 | 2021 | 874 | 0.200 |
Why?
|
| Muscle Weakness | 1 | 2024 | 88 | 0.200 |
Why?
|
| Dexamethasone | 1 | 2024 | 250 | 0.190 |
Why?
|
| Demyelinating Diseases | 1 | 2023 | 68 | 0.190 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2023 | 37 | 0.190 |
Why?
|
| Ataxia | 1 | 2024 | 160 | 0.180 |
Why?
|
| Child | 14 | 2026 | 26235 | 0.180 |
Why?
|
| Cerebellum | 1 | 2026 | 441 | 0.180 |
Why?
|
| Eating | 1 | 2024 | 376 | 0.180 |
Why?
|
| Adolescent | 10 | 2026 | 20876 | 0.170 |
Why?
|
| Epileptic Syndromes | 1 | 2020 | 35 | 0.160 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 55 | 0.160 |
Why?
|
| Seizures, Febrile | 1 | 2020 | 32 | 0.160 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 567 | 0.150 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 3 | 2023 | 35 | 0.140 |
Why?
|
| Retrospective Studies | 9 | 2026 | 17650 | 0.130 |
Why?
|
| Diet | 1 | 2024 | 1113 | 0.130 |
Why?
|
| Humans | 18 | 2026 | 130515 | 0.110 |
Why?
|
| Male | 11 | 2026 | 64587 | 0.110 |
Why?
|
| Female | 12 | 2026 | 70546 | 0.100 |
Why?
|
| Aquaporin 4 | 2 | 2023 | 16 | 0.100 |
Why?
|
| Disease Progression | 3 | 2024 | 2192 | 0.090 |
Why?
|
| Rituximab | 2 | 2024 | 170 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1874 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2021 | 269 | 0.070 |
Why?
|
| Recurrence | 2 | 2023 | 1482 | 0.070 |
Why?
|
| Registries | 2 | 2026 | 1614 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2026 | 15028 | 0.070 |
Why?
|
| Atrophy | 1 | 2026 | 247 | 0.060 |
Why?
|
| Injections | 1 | 2025 | 109 | 0.060 |
Why?
|
| Injections, Subcutaneous | 1 | 2025 | 136 | 0.060 |
Why?
|
| United States | 3 | 2026 | 12009 | 0.060 |
Why?
|
| Injections, Intramuscular | 1 | 2025 | 185 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2025 | 12851 | 0.060 |
Why?
|
| Phenotype | 2 | 2026 | 4459 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2026 | 5048 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2024 | 45 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2024 | 129 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2025 | 531 | 0.050 |
Why?
|
| Dairy Products | 1 | 2024 | 42 | 0.050 |
Why?
|
| Lymphocyte Depletion | 1 | 2024 | 124 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2025 | 232 | 0.050 |
Why?
|
| Inflammation | 1 | 2021 | 1481 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2025 | 709 | 0.050 |
Why?
|
| Age of Onset | 1 | 2024 | 592 | 0.050 |
Why?
|
| Azathioprine | 1 | 2022 | 35 | 0.050 |
Why?
|
| Fruit | 1 | 2024 | 227 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2023 | 86 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 165 | 0.050 |
Why?
|
| Demography | 1 | 2023 | 236 | 0.050 |
Why?
|
| Fever | 1 | 2024 | 312 | 0.040 |
Why?
|
| Infectious Encephalitis | 1 | 2020 | 5 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2026 | 809 | 0.040 |
Why?
|
| Syndrome | 1 | 2023 | 1154 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1484 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 560 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 782 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2024 | 6424 | 0.020 |
Why?
|
| Brain | 1 | 2024 | 3165 | 0.020 |
Why?
|
| Infant | 1 | 2026 | 13293 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 31115 | 0.010 |
Why?
|